$2.12
0.010.47%
At close: Aug 11, 5:00 PM EST
$2.13
0.010.47%
After Hours: 9:09 AM EST
Grace Therapeutics (GRCE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.21 | $-0.27 | $-0.25 | $-0.31 |
| Actual | $-0.06 | $-0.14 | $-0.06 | $-0.21 |
| Surprise | +71.4% | +48.1% | +76.0% | +32.3% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q1 '27E | Q2 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.18 | $-0.18 |
| Revenue | ||
| Consensus | $545000 | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | Jun 18, 2026 | $-0.06 | $-0.21 | 71.4 % |
| Q3 | Feb 12, 2026 | $-0.14 | $-0.27 | 48.1 % |
| Q2 | Nov 13, 2025 | $-0.06 | $-0.25 | 76.0 % |
| Q1 | Aug 12, 2025 | $-0.21 | $-0.31 | 32.3 % |